Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05017831 · ClinicalTrials.gov registry record · NA

Shifting Perspectives R33 Phase: Enhancing Outcomes in Anorexia Nervosa With CRT

A NA study, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
283
Enrollment target

NCT05017831 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 283 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05017831, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
283 participants
Enrollment target

Study Summary

Anorexia Nervosa is a serious life-threatening illness with a typical age of onset in adolescence; if not effectively treated, it has the potential to significantly impact adolescent development and quality of life. Research on executive functioning in anorexia nervosa indicates that it may be a viable target for intervention that could improve outcome. The current project focuses on determining whether or not the investigators can improve set-shifting in affected adolescents in the hopes that improvements in set-shifting will, ultimately, improve outcome.

Interventions

  • BEHAVIORAL Cognitive Remediation Therapy
  • BEHAVIORAL Family Based Treatment

Trial Details

FieldValue
Enrollment Target 283 participants
Start Date 2021-11-05
Est. Completion 2025-05-21
Phase NA

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT05017831

The ClinicalTrials.gov registry entry for NCT05017831 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 283 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Cognitive Remediation Therapy is the first listed.

NCT05017831 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05017831 about?

NCT05017831 is a clinical study titled "Shifting Perspectives R33 Phase: Enhancing Outcomes in Anorexia Nervosa With CRT". Anorexia Nervosa is a serious life-threatening illness with a typical age of onset in adolescence; if not effectively treated, it has the potential to significantly impact adolescent development and quality of life. Research on executive functioning in anorexia nervosa indicates that it may be a via...

What is the current status of trial NCT05017831?

This trial is currently completed. It is a NA study. The enrollment target is 283 participants. The study started on 2021-11-05. Estimated completion is 2025-05-21.

What interventions are being tested in trial NCT05017831?

The interventions under investigation include: Cognitive Remediation Therapy (BEHAVIORAL), Family Based Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT05017831?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.